December 18, 2006

AHRQ No Evidence to Support Off-Label Uses of Atypical Antipsychotics

A new federally funded study by HHS Agency for Healthcare Research andQuality,  found little or no evidence

Read More
AHRQ No Evidence to Support Off-Label Uses of Atypical Antipsychotics

December 16, 2006

Texas Attorney General Joins Whistleblower Lawsuit against J & J

1. The Texas Attorney General, Greg Abbott,  has joined a whistleblower's lawsuit against one of the giants

Read More
Texas Attorney General Joins Whistleblower Lawsuit against J & J

December 1, 2006

New Schizophrenia Drugs No Better Than CheaperGenerics_Bloomberg_WashPost

The second phase of the government study, Clinical Antipsychotic Trials inIntervention Effectiveness (CATIE), was released and the

Read More
New Schizophrenia Drugs No Better Than CheaperGenerics_Bloomberg_WashPost

November 21, 2006

Former State Pharmacist (Pennsylvania) Faces Criminal charges

Business Week reports (below) that Fiorello is charged with accepting money and other perks from companies who have

Read More
Former State Pharmacist (Pennsylvania) Faces Criminal charges

October 26, 2006

Janssen Admits Hiding Risperdal Risks / TMAP & Illinois Mental Health Screening

Janssen Pharma Admits Hiding Risperdal Drug Risks / TMAP & Illinois Mental Health Screening Plan Sat, 24

Read More
Janssen Admits Hiding Risperdal Risks / TMAP & Illinois Mental Health Screening

October 26, 2006

Mental Health Screening: A Form of Child Abuse–Children Drugged Without Parental Consent

Mental Health Screening: A Form of Child Abuse–Children Drugged Without Parental Consent Tue, 19 Apr 2005 The

Read More
Mental Health Screening: A Form of Child Abuse–Children Drugged Without Parental Consent

October 26, 2006

Antipsychotic Drug Use Doubled since 1996 in Tennessee Children – Why?

Antipsychotic Drug Use Doubled since 1996 in Tennessee Children – Why? Thu, 2 Sep 2004 A Vanderbilt

Read More
Antipsychotic Drug Use Doubled since 1996 in Tennessee Children – Why?

October 26, 2006

Psychopharmacology in Turmoil: David Healy, MD Presentation Columbia + Debate Dr. Joseph Coyne, Ph.D

Psychopharmacology in Turmoil: David Healy, MD Presentation Columbia + Debate Dr. Joseph Coyne, Ph.D Fri, 9 Dec

Read More
Psychopharmacology in Turmoil: David Healy, MD Presentation Columbia + Debate Dr. Joseph Coyne, Ph.D

October 26, 2006

Bush Plans to Screen Whole US Population for Mental Illness – BMJ

Bush Plans to Screen Whole US Population for Mental Illness – BMJ Thu, 24 Jun 2004 A

Read More
Bush Plans to Screen Whole US Population for Mental Illness – BMJ

October 26, 2006

AHRP Position Statement on Mental Health Screening – FDA Hearing Re: Drug Advertising

AHRP Position Statement on Mental Health Screening – FDA Hearing Re: Drug Advertising Wed, 02 Nov 2005

Read More
AHRP Position Statement on Mental Health Screening – FDA Hearing Re: Drug Advertising

October 26, 2006

Conflicts of Interest policy – New York Times

Conflicts of Interest policy – New York Times Sun, 28 Mar 2004 To: ‘Executive-editor@nytimes’; ‘gcollins@nytimes’; ‘arosenthal@nytimes’; ‘pboffey@nytimes’;

Read More
Conflicts of Interest policy – New York Times

October 26, 2006

NYT Editorial: comparing schizophrenia drugs

NYT Editorial: comparing schizophrenia drugs Wed, 21 Sep 2005 Today’s New York Times Editorial acknowledges: “A government-financed

Read More
NYT Editorial: comparing schizophrenia drugs

October 26, 2006

Go Slow on Mental Health Screening: Dr. Effrem Responds to New Freedom Commission Chair

Go Slow on Mental Health Screening: Dr. Karen Effrem responds to New Freedom Commission Chair, Michael Hogan

Read More
Go Slow on Mental Health Screening: Dr. Effrem Responds to New Freedom Commission Chair

October 26, 2006

Federal Study Finds No Benefit of New Antipsychotic Drugs – WashPost/Wall StreetJ/NY Times

Federal Study Finds No Benefit of New Antipsychotic Drugs – WashPost/Wall StreetJ/NY Times Tue, 20 Sep 2005

Read More
Federal Study Finds No Benefit of New Antipsychotic Drugs – WashPost/Wall StreetJ/NY Times